TEMOZOLOMIDE , KEYTRUDA 25 mg/mL concentrate for solution for infusion, saline solution for infusion
EF-41/KEYNOTE D58
Phase 3 small_molecule active
Quick answer
TEMOZOLOMIDE , KEYTRUDA 25 mg/mL concentrate for solution for infusion, saline solution for infusion for Newly diagnosed Glioblastoma is a Phase 3 program (small_molecule) at Novo mesto with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo mesto
- Indication
- Newly diagnosed Glioblastoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active